These results revealed that SLC30A1 and SLC30A10 were both associated with immune cells, immunostimulators, immunoinhibitors and MHC molecules, suggesting that SLC30A1/10 may contribute to the malignant behavior of cervical cancer cells by influencing immune factors. This evidence concerns the gene HLA-C and cervical carcinoma.